Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Current Topics in Medicinal Chemistry
|
February 4, 2006
Decision tree methods in pharmaceutical research
Paul E Blower, Kevin P Cross
Current Opinion in Drug Discovery & Development
|
June 13, 2002
Multiscale and Bayesian approaches to data analysis in genomics high-throughput screening
Chihae Yang, Bhavik R Bakshi, James F Rathman, et al.
Journal of Medicinal Chemistry
|
November 13, 2004
Building predictive models for protein tyrosine phosphatase 1B inhibitors based on discriminating structural features by reassembling medicinal chemistry building blocks
Chihae Yang, Kevin Cross, Glenn J Myatt, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 17, 2009
Pharmacogenomic approach reveals a role for the x(c)- cystine/glutamate antiporter in growth and celastrol resistance of glioma cell lines
Anh-Nhan Pham, Paul E Blower, Omar Alvarado, et al.
Journal of Medicinal Chemistry
|
October 17, 2003
Finding discriminating structural features by reassembling common building blocks
Kevin P Cross, Glenn Myatt, Chihae Yang, et al.
Combinatorial Chemistry & High Throughput Screening
|
February 16, 2006
Comparison of methods for sequential screening of large compound sets
Paul E Blower, Kevin P Cross, Gabriel S Eichler, et al.
Current Drug Discovery Technologies
|
February 14, 2006
Systematic analysis of large screening sets in drug discovery
Paul E Blower, Kevin P Cross, Michael A Fligner, et al.
Pharmaceutical Research
|
April 26, 2007
Chemogenomic analysis identifies geldanamycins as substrates and inhibitors of ABCB1
Ying Huang, Paul E Blower, Ruqing Liu, et al.
Pharmaceutical Research
|
December 11, 2008
Pharmacogenomics approach reveals MRP1 (ABCC1)-mediated resistance to geldanamycins
Anh-Nhan Pham, Jeffrey Wang, Jialong Fang, et al.
Molecular Cancer Therapeutics
|
June 6, 2008
In vitro differential sensitivity of melanomas to phenothiazines is based on the presence of codon 600 BRAF mutation
Ogechi N Ikediobi, Mark Reimers, Steffen Durinck, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Current Topics in Medicinal Chemistry
|
February 4, 2006
Decision tree methods in pharmaceutical research
Paul E Blower, Kevin P Cross
Current Opinion in Drug Discovery & Development
|
June 13, 2002
Multiscale and Bayesian approaches to data analysis in genomics high-throughput screening
Chihae Yang, Bhavik R Bakshi, James F Rathman, et al.
Journal of Medicinal Chemistry
|
November 13, 2004
Building predictive models for protein tyrosine phosphatase 1B inhibitors based on discriminating structural features by reassembling medicinal chemistry building blocks
Chihae Yang, Kevin Cross, Glenn J Myatt, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 17, 2009
Pharmacogenomic approach reveals a role for the x(c)- cystine/glutamate antiporter in growth and celastrol resistance of glioma cell lines
Anh-Nhan Pham, Paul E Blower, Omar Alvarado, et al.
Journal of Medicinal Chemistry
|
October 17, 2003
Finding discriminating structural features by reassembling common building blocks
Kevin P Cross, Glenn Myatt, Chihae Yang, et al.
Combinatorial Chemistry & High Throughput Screening
|
February 16, 2006
Comparison of methods for sequential screening of large compound sets
Paul E Blower, Kevin P Cross, Gabriel S Eichler, et al.
Current Drug Discovery Technologies
|
February 14, 2006
Systematic analysis of large screening sets in drug discovery
Paul E Blower, Kevin P Cross, Michael A Fligner, et al.
Pharmaceutical Research
|
April 26, 2007
Chemogenomic analysis identifies geldanamycins as substrates and inhibitors of ABCB1
Ying Huang, Paul E Blower, Ruqing Liu, et al.
Pharmaceutical Research
|
December 11, 2008
Pharmacogenomics approach reveals MRP1 (ABCC1)-mediated resistance to geldanamycins
Anh-Nhan Pham, Jeffrey Wang, Jialong Fang, et al.
Molecular Cancer Therapeutics
|
June 6, 2008
In vitro differential sensitivity of melanomas to phenothiazines is based on the presence of codon 600 BRAF mutation
Ogechi N Ikediobi, Mark Reimers, Steffen Durinck, et al.
Page
of 2